Read selected news articles about Evestra, our ongoing work, and our future projects.
Evestra, Inc. announced today that the Bill & Melinda Gates Foundation has given a grant to Evestra to advance the preclinical and clinical development of a novel long-acting injectable contraceptive product for women in underserved…
SAN ANTONIO (September 6, 2022) – The Mays Cancer Center at UT Health San Antonio and a local partner have been awarded a five-year, $3.3 million Academic Industry Partnership grant from the National Institutes of Health (NIH). It is the…
Details
In November 2020, Evestra, Inc. received a grant from the Bill and Melinda Gates Foundation to develop a twice-yearly injectable contraceptive. The goal of this project is to enable greater access to modern contraceptives for…
Details
SCHERTZ, Texas – Evestra, Inc. this week European partner Gedeon Richter becomes equity shareholder as the company celebrates 10 years.
Evestra, Inc. has received a grant from the Department of Defense (DoD) to develop a novel first-in-class LIF (Leukemia Inhibitory Factory) to treat triple negative breast cancer (TNBC). The grant proposal, entitled “Targeted Inhibition of…
Details